Current evidence on the efficacy of deep dermal injection of non-absorbable gel polymer (NAGP) for HIV-related facial lipoatrophy is adequate. With regard to safety, infections that may need surgical ...

Please provide your email address to receive an email when new articles are posted on . Three preclinical models were used to evaluate GraftJacket Acellular Periosteum Replacement Scaffold (Wright ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

2.1.1 Lipoatrophy is the localised loss of fat from within subcutaneous tissue. It can be a congenital condition or can be associated with subcutaneous injection sites. Facial lipoatrophy is commonly ...